Robert S. Wallis, MD, FIDSA
Robert S. Wallis, MD, FIDSA
CSO, Aurum Institute; Prof Medicine, CWRU, Rutgers & Vanderbilt
Bekræftet mail på po.cwru.edu - Startside
Titel
Citeret af
Citeret af
År
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis, MS Broder, JY Wong, ME Hanson, DO Beenhouwer
Clinical infectious diseases 38 (9), 1261-1265, 2004
11362004
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
RS Wallis, M Pai, D Menzies, TM Doherty, G Walzl, MD Perkins, A Zumla
The lancet 375 (9729), 1920-1937, 2010
5622010
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
I Solovic, M Sester, JJ Gomez-Reino, HL Rieder, S Ehlers, HJ Milburn, ...
European Respiratory Journal 36 (5), 1185-1206, 2010
5262010
Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy
CS Hirsch, Z Toossi, C Othieno, JL Johnson, SK Schwander, S Robertson, ...
Journal of Infectious Diseases 180 (6), 2069-2073, 1999
3621999
Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
RS Wallis
The Lancet infectious diseases 8 (10), 601-611, 2008
3052008
Biomarkers for tuberculosis disease activity, cure, and relapse
RS Wallis, TM Doherty, P Onyebujoh, M Vahedi, H Laang, O Olesen, ...
The Lancet infectious diseases 9 (3), 162-172, 2009
2832009
Granulomatous infections due to tumor necrosis factor blockade: correction
RS Wallis, M Broder, J Wong, D Beenhouwer
Clinical Infectious Diseases 39 (8), 1254-1255, 2004
2612004
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
MJ Boeree, N Heinrich, R Aarnoutse, AH Diacon, R Dawson, S Rehal, ...
The Lancet infectious diseases 17 (1), 39-49, 2017
2602017
Tuberculosis biomarkers discovery: developments, needs, and challenges
RS Wallis, P Kim, S Cole, D Hanna, BB Andrade, M Maeurer, M Schito, ...
The Lancet infectious diseases 13 (4), 362-372, 2013
2572013
Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection
DE Furst, R Wallis, M Broder, DO Beenhouwer
Seminars in arthritis and rheumatism 36 (3), 159-167, 2006
2552006
Advancing host-directed therapy for tuberculosis
RS Wallis, R Hafner
Nature Reviews Immunology 15 (4), 255-263, 2015
2512015
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
RS Wallis, P Kyambadde, JL Johnson, L Horter, R Kittle, M Pohle, ...
Aids 18 (2), 257-264, 2004
2512004
Tuberculosis—advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
RS Wallis, M Maeurer, P Mwaba, J Chakaya, R Rustomjee, GB Migliori, ...
The Lancet infectious diseases 16 (4), e34-e46, 2016
2452016
Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity
OY Saliu, C Sofer, DS Stein, SK Schwander, RS Wallis
The Journal of infectious diseases 194 (4), 486-492, 2006
2372006
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
A Zumla, M Rao, RS Wallis, SHE Kaufmann, R Rustomjee, P Mwaba, ...
The Lancet Infectious Diseases 16 (4), e47-e63, 2016
2182016
Human immune response to Mycobacterium tuberculosis antigens
DV Havlir, RS Wallis, WH Boom, TM Daniel, K Chervenak, JJ Ellner
Infection and Immunity 59 (2), 665-670, 1991
2171991
Reactivation of latent granulomatous infections by infliximab
RS Wallis, M Broder, J Wong, A Lee, L Hoq
Clinical infectious diseases 41 (Supplement_3), S194-S198, 2005
2162005
Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot
RS Wallis, M Amir-Tahmasseb, JJ Ellner
Proceedings of the National Academy of Sciences 87 (9), 3348-3352, 1990
2101990
Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes
TK Blackmore, L Manning, WJ Taylor, RS Wallis
Clinical Infectious Diseases 47 (10), e83-e85, 2008
1852008
Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes
WH Boom, RS Wallis, KA Chervenak
Infection and immunity 59 (8), 2737-2743, 1991
1831991
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20